Get The App!
Loading the player...
What do the results of the COMFORT I and II trial mean to patients? (Video 5 of 5).
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
A discussion with Dr. Claire Harrison on what the results from the COMFORT II trial means for patients. - EHA 2011. (Video 5 of 5)
Myeloproliferative Neoplasms: Clinical Presentation and Diagnosis
Update on JAK Inhibitor — Spleen Volume Reduction and OS interview with Srdan Verstovsek, MD, PhD, a...
Update on JAK Inhibitor — COMFORT II Trial interview with Claire Harrison, MD, at ASH 2011
JAK Inhibitor Ruxolitinib COMFORT-II Trial Shows Positive Results - ASCO 2011
COMFORT II - Why is spleen volume so important? and other questions with Dr. Claire Harrison
COMFORT II Additional Data Discussion with Dr. Claire Harrison
COMFORT II Discussion with Dr. Claire Harrison on the Side Effects of the Trial
What Are Myeloproliferative Neoplasms (MPNs)?
Copyright 2020 by NSCI Group, Inc.
On The Go
About MedEd On The Go